Statistics for Experience in the use of sunitinib given as a single agent in metastatic chemoresistant and castration-resistant prostate cancer patients.
Total visits
views | |
---|---|
Experience in the use of sunitinib given as a single agent in metastatic chemoresistant and castration-resistant prostate cancer patients. | 22 |
Total visits per month
views | |
---|---|
marzo 2024 | 0 |
abril 2024 | 1 |
mayo 2024 | 3 |
junio 2024 | 0 |
julio 2024 | 0 |
agosto 2024 | 0 |
septiembre 2024 | 0 |
File Visits
views | |
---|---|
aff98de1-38b1-4538-aeef-8d6c6e684c66 | 2 |